1. Individualized therapy for malignant tumors: Expertise in formulating precision personalized treatment plans based on molecular pathology, genetic testing and clinical profiles of patients. 2. Oncological postoperative rehabilitation and comprehensive medical management: Specializes in whole-course rehabilitation management for postoperative tumor patients, covering nutritional intervention, complication prevention and management, and psychological intervention. 3. Cellular immunotherapy: Proficient in advanced cellular immunotherapies including CAR-T, NK cell and TIL cell therapy, delivering alternative treatment options for patients with refractory malignancies. 4. Early tumor screening and diagnosis: Performs targeted early detection and diagnosis of tumors via multimodal assessment incorporating imaging examination, endoscopy and liquid biopsy. 5. Tumor-associated and systemic diseases: Malignant tumors (hepatic carcinoma, lung cancer, renal carcinoma, bladder cancer, cervical c

Tang Maoshun, Associate Chief Physician, bachelor’s degree. Nearly 30 years of clinical experience, 15+ years in minimally invasive interventional diagnosis and treatment. Expertise in malignant tumors (hepatocellular carcinoma, lung cancer, renal cell carcinoma, bladder cancer, cervical cancer, prostate cancer, colorectal cancer, head and neck malignancies); benign tumors (hepatic cavernous hemangioma, focal nodular hyperplasia, hepatic/renal hamartoma, uterine leiomyoma, adenomyosis); malignant obstructive jaundice, portal hypertension, hypersplenism; hyperthyroidism; benign prostatic hyperplasia; simple obesity; hepatic/renal cysts; other tumor-related diseases); peripheral vascular diseases (arterial stenosis, arteriosclerosis obliterans, diabetic foot, aneurysm, arteriovenous malformation, deep vein thrombosis, pulmonary embolism, stenosis/occlusion of dialysis access); hemorrhagic diseases (massive hemoptysis, postpartum hemorrhage, gastrointestinal bleeding, traumatic hemorrhage, variceal bleeding due to portal hypertension, spontaneous tumor rupture, iatrogenic bleeding). Has performed over 10,000 interventional procedures. Proficient in comprehensive tumor intervention, peripheral vascular intervention, and neurointervention. Published over 10 papers, including 1 SCI article. Provides a "third modality" of diagnosis and treatment—minimally invasive interventional diagnosis and treatment—beyond surgery and internal medicine.